8-K/AThe WireStrategic
Material Agreement · Equity Issuance
Filed Dec 11, 2019 · 6y ago · Accession 0001628280-19-014943
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- 8-K/A
- Filing date
- Dec 11, 2019
- Report date
- Dec 5, 2019
- Document
- a8-kaamendment1xaevimerger.htm
- Size
- 516 KB